Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer
Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable
FDA Approves Gleevec For First Line Rx Of CML
Fragmin Cuts Risk Of VE By 50 Percent In Study
Sirolimus-Containing Therapy Reduces GVHD, Study Finds
Avastin Regimen Bested Chemo Alone In Early Disease
Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca
Study Confirms Cancer Risk Increase Due To Combined HRT
Pill Associated With Cancer In BRCA1 Mutation Carriers
National Cancer Institute Lists Approved Clinical Trials
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97
An architect of today’s Roswell Park
